Immage Biotherapeutics Accounts Payable

Immage Biotherapeutics (IMMG) currently reports a accounts payable of $48K as of February 2017. That compares with $16 in the prior-year period — up 301081.3% year over year. Use the charts on this page to explore Immage Biotherapeutics's accounts payable history and peer comparisons.

Immage Biotherapeutics's accounts payable increased from $16 to $48K — a 301081.3% year-over-year increase (period ending February 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immage Biotherapeutics reported $48K in accounts payable as of February 2017. That compares with $16 in the prior-year period — up 301081.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $48K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immage Biotherapeutics, and consider following IMMG for alerts when major investors trade the stock.